Wanbury receives EIR from USFDA for Patalganga facility

Wanbury has announced that the USFDA has issued an Establishment Inspection Report ("EIR") for the Company's manufacturing facility located at MIDC Industrial Area, Patalganga, Maharashtra, India and the inspection has now been successfully closed by the USFDA. USFDA has determined that the inspection classification of this facility is "No Action Indicated" (NAI) with zero 483 observation.

Based on this inspection, this facility is considered to be in an acceptable state of compliance with regards to current good manufacturing practice (CGMP).

Shares of Wanbury Limited was last trading in BSE at Rs. 210.00 as compared to the previous close of Rs. 202.55. The total number of shares traded during the day was 24102 in over 806 trades.

The stock hit an intraday high of Rs. 212.65 and intraday low of 205.00. The net turnover during the day was Rs. 5040794.00.

Source : Equity Bulls

Keywords

Wanbury INE107F01022 USFDA EIR Patalganga ManufacturingFacility